Literature DB >> 19376103

Metabolic biomarkers related to energy metabolism in Saudi autistic children.

O A Al-Mosalem1, A El-Ansary, O Attas, L Al-Ayadhi.   

Abstract

OBJECTIVES: Energy metabolism is usually manipulated in many neurodegenerative diseases. Autism is considered a definable systemic disorder resulting in a number of diverse factors that may affect the brain development and functions both pre and post natal. The increased prevalence of autism will have enormous future public implications and has stimulated intense research into potential etiologic factors. This study aims to establish a connection between autism and the deterioration accompanied it, especially in the brain cognitive areas through a postulation of energy manipulation.
MATERIALS AND METHODS: The biochemical changes in activities of enzymes and pathways that participate in the production of ATP as the most important high-energy compound needed by the human brain were measured in Saudi autistic children. Na(+)/K(+)ATPase, ectonucleotidases (NTPDases) (ADPase and ATPase) and creatine kinase (CK), were assessed in plasma of 30 Saudi autistic patients and compared to 30 age-matching control samples. In addition, adenosine mono, di and trinucleotides (ATP, ADP, and AMP) were measured calorimetrically in the red blood cells of both groups and the adenylate energy charge (AEC) was calculated. Moreover, lactate concentration in plasma of both groups was monitored.
RESULTS: The obtained data recorded 148.77% and 72.35% higher activities of Na(+)/K(+)ATPase and CK respectively in autistic patients which prove the impairment of energy metabolism in these children compared to age and sex matching healthy controls. While ADPase was significantly higher in autistic patients, ATPase were non-significantly elevated compared to control. In spite of the significant increase of Na(+)/K(+)ATPase activity in autistic patients, there was no significant difference in the levels of ATP, ADP, and AMP in both groups and the calculated AEC values were 0.814+/-0.094 and 0.806+/-0.081 for autistic and control groups respectively. The unchanged AEC value in autistic patients was easily correlated with the induced activity of CK and ADPase as two enzymes playing a critical role in the stabilization of AEC. Lactate as an important energy metabolite for the brain was significantly higher in autistic patients compared to control showing about 40% increase.
CONCLUSION: The present study confirmed the impairment of energy metabolism in Saudi autistic patients which could be correlated to the oxidative stress previously recorded in the same investigated samples. The identification of biochemical markers related to autism would be advantageous for earlier clinical diagnosis and intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19376103     DOI: 10.1016/j.clinbiochem.2009.04.006

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  33 in total

1.  Sodium-potassium ATPase emerges as a player in hippocampal phenotypes of Angelman syndrome mice.

Authors:  Jada J Hallengren; Ryan J Vaden
Journal:  J Neurophysiol       Date:  2014-02-05       Impact factor: 2.714

Review 2.  Advances in the design of nanomaterial-based electrochemical affinity and enzymatic biosensors for metabolic biomarkers: A review.

Authors:  Leila Farzin; Mojtaba Shamsipur; Leila Samandari; Shahab Sheibani
Journal:  Mikrochim Acta       Date:  2018-05-02       Impact factor: 5.833

3.  Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers.

Authors:  Asma M Khemakhem; Richard E Frye; Afaf El-Ansary; Laila Al-Ayadhi; Abir Ben Bacha
Journal:  Metab Brain Dis       Date:  2017-08-22       Impact factor: 3.584

4.  Autism spectrum disorders associated to a deficiency of the enzymes of the mitochondrial respiratory chain.

Authors:  José Guevara-Campos; Lucía González-Guevara; Carmen Puig-Alcaraz; Omar Cauli
Journal:  Metab Brain Dis       Date:  2013-07-10       Impact factor: 3.584

5.  Predictive value of selected biomarkers related to metabolism and oxidative stress in children with autism spectrum disorder.

Authors:  Afaf El-Ansary; Geir Bjørklund; Salvatore Chirumbolo; Osima M Alnakhli
Journal:  Metab Brain Dis       Date:  2017-05-11       Impact factor: 3.584

6.  Alterations in intrinsic membrane properties and the axon initial segment in a mouse model of Angelman syndrome.

Authors:  Hanoch Kaphzan; Shelly A Buffington; Joo In Jung; Matthew N Rasband; Eric Klann
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

7.  The neonatal levels of TSB, NSE and CK-BB in autism spectrum disorder from Southern China.

Authors:  Meng-Na Lv; Hong Zhang; Yi Shu; Shan Chen; Yuan-Yuan Hu; Min Zhou
Journal:  Transl Neurosci       Date:  2016-02-18       Impact factor: 1.757

8.  Analysis of Extracellular Nucleotide Metabolism in Adult Zebrafish After Embryological Exposure to Valproic Acid.

Authors:  Fernanda Francine Zimmermann; Karina Vidarte Gaspary; Anna Maria Siebel; Carlos Eduardo Leite; Luiza Wilges Kist; Mauricio Reis Bogo; Carla Denise Bonan
Journal:  Mol Neurobiol       Date:  2016-05-17       Impact factor: 5.590

9.  Genetic reduction of the α1 subunit of Na/K-ATPase corrects multiple hippocampal phenotypes in Angelman syndrome.

Authors:  Hanoch Kaphzan; Shelly A Buffington; Akila B Ramaraj; Jerry B Lingrel; Matthew N Rasband; Emanuela Santini; Eric Klann
Journal:  Cell Rep       Date:  2013-08-01       Impact factor: 9.423

Review 10.  Emerging biomarkers in autism spectrum disorder: a systematic review.

Authors:  Richard E Frye; Sarah Vassall; Gurjot Kaur; Christina Lewis; Mohammand Karim; Daniel Rossignol
Journal:  Ann Transl Med       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.